PathAI Launches Precision Pathology Network to Advance AI-Powered Pathology
First-of-its-kind digital pathology network powered by PathAI’s AISight® platform expands access to latest AI products, unlocks real-world data value, and...
Healthcare
Privia Health Announces Appointment of Lance V. Berberian to its Board of Directors
Berberian brings significant technology leadership and cybersecurity expertiseARLINGTON, Va., July 08, 2025 (GLOBE NEWSWIRE) -- Privia Health Group, Inc. (Nasdaq:...
Clover Health to Report Second Quarter 2025 Financial Results on August 5, 2025
WILMINGTON, Del., July 08, 2025 (GLOBE NEWSWIRE) -- Clover Health Investments, Corp. (Nasdaq: CLOV) (“Clover,” “Clover Health” or the “Company”),...
QHS Healthcare, Powered by QHSLab, Inc. (OTCQB: USAQ), Opens Doors in Miami to Expand Access to Mental Health Services
Innovative initiative combines QHSLab’s digital platform with on-site behavioral health services to advance timely, effective care. MIAMI, FL, July 08,...
Fifty 1 Labs, Inc. Announces Bold Expansion Plan Powered by Nobel Prize Laureate Management Team, Cutting-Edge AI Healthcare Innovation and $350K Leadership Investment
Company Targets OTCQB and NASDAQ Uplisting With Breakthroughs in Drug Repurposing, Functional Medicine, and Strategic AcquisitionsSEATTLE, July 08, 2025 (GLOBE...
SlimJaro Botanical Approaches Gain Interest in 2025 for Inflammation-Related Metabolic Wellness
A new category of plant-based formulations is gaining attention for their role in supporting internal balance and inflammation-linked metabolic concerns....
SRX Health Completes $7.3 Million Financing Led by Insiders and Existing Investors and Announces Financial Commitment of Up to $50 Million
TAMPA, Fla., July 08, 2025 (GLOBE NEWSWIRE) -- SRx Health Solutions, Inc. (NYSE American: SRXH) (“SRX Health” or the “Company”),...
Progyny, Inc. Provides Business Update and Announces Details for Its Second Quarter 2025 Results Report
Operational and Financial Flexibility Enhanced Through New Credit FacilitySecond Quarter Results Anticipated to be Slightly Above Previously Provided Financial Guidance...
SeaStar Medical Expands QUELIMMUNE Adoption for Critically Ill Pediatric Patients with Acute Kidney Injury (AKI)
Nationally Recognized Texas Children’s Hospital Adds First-In-Class Therapy as a Potential Life-Saving Treatment in Ultra-Rare Cases of Pediatric AKIDENVER, July...
Alignment Healthcare Wins Key Legal Victory: Arizona Medicare Advantage Plans Elevated to 4 Stars
Court ruling means 100% of Alignment’s members now enrolled in plans rated 4 stars or greaterORANGE, Calif., July 08, 2025 (GLOBE...
Humacyte announces Symvess™ ECAT Approval from U.S. Defense Logistics Agency
Electronic Catalog listing approval makes Symvess available to healthcare professionals at U.S. Department of Defense and U.S. Department of Veterans...
Beacon Therapeutics completes enrollment in registrational Phase 2/3 VISTA trial of laru-zova for patients with XLRP
Topline data expected in H2 2026 LONDON and CAMBRIDGE, Mass., July 08, 2025 (GLOBE NEWSWIRE) -- Beacon Therapeutics Holdings Limited...
Medvantx Acquires RxS to Broaden Integrated Access & Engagement Solutions for Life Science
Combined company will leverage services and technology platforms to offer a broad portfolio of integrated solutions to pharmaceutical and device...
Eupraxia Doses First Patient in Phase 2b Placebo-Controlled Portion of EP-104GI RESOLVE Trial in Eosinophilic Esophagitis
Dosing of the first patient in Phase 2b marks an important transition of the RESOLVE trial from a Phase 2a...
Agios Appoints Dr. Jay Backstrom to Board of Directors
CAMBRIDGE, Mass., July 08, 2025 (GLOBE NEWSWIRE) -- Agios Pharmaceuticals, Inc. (Nasdaq: AGIO), a leader in cellular metabolism and pyruvate...
WeightWatchers Completes Financial Reorganization, Strengthens Leadership, and Expands Program Innovation to Support Women Through Menopause
With renewed financial strength, WeightWatchers accelerates its transformation with the appointment of key executives including Dr. Kim Boyd as Chief...
UAE Approves BioAro’s Longevity+ Supplement, Signaling Major Market Potential in Global Preventive Health
With a patent-pending formula and international expansion underway, BioAro positions itself as a front-runner in the multi-billion-dollar longevity and wellness...
Novartis receives approval for first malaria medicine for newborn babies and young infants
Coartem® (artemether-lumefantrine) Baby becomes first malaria treatment approved for newborn babies and young infants Rapid approvals in eight African countries...
Ascentage Pharma Appoints Dr. Veet Misra as Chief Financial Officer and Eric Huang as Senior Vice President of Global Corporate Development and Finance
ROCKVILLE, Md. and SUZHOU, China, July 07, 2025 (GLOBE NEWSWIRE) -- Ascentage Pharma Group International (NASDAQ: AAPG; HKEX: 6855) (“Ascentage...
Aphobic Launches AI-Powered Phobia Relief App to Revolutionize Phobia Support
GLENBROOK, Nev., July 8, 2025 /PRNewswire/ -- Aphobic, the world's first AI-powered phobia relief app from Rockridge AI, Inc., launches...